{
  "resourceType": "ValueSet",
  "id": "oncology-MorphologyBehaviorVS",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n<p><b>BC MorphologyBehaviorVS ValueSet</b></p>\n<p>The morphologic behavior of the cancer. These are the suffix to the ICD-O-3 histologic type codes. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher.</p>\n</div>"
  },
  "url": "http://hl7.org/fhir/us/breastcancer/ValueSet/oncology-MorphologyBehaviorVS",
  "identifier": [
    {
      "system": "http://hl7.org/fhir/us/breastcancer",
      "value": "oncology.MorphologyBehaviorVS"
    }
  ],
  "name": "MorphologyBehaviorVS",
  "title": "BC MorphologyBehaviorVS ValueSet",
  "status": "draft",
  "publisher": "The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC)",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://standardhealthrecord.org"
        }
      ]
    }
  ],
  "date": "2018-05-02",
  "description": "The morphologic behavior of the cancer. These are the suffix to the ICD-O-3 histologic type codes. Codes are presented as local codes due to the lack of a ICD-O-3 terminology server available to the FHIR IG publisher.",
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-MorphologyBehaviorCS",
        "concept": [
          {
            "code": "0",
            "display": "Benign"
          },
          {
            "code": "1",
            "display": "Uncertain whether benign or malignant"
          },
          {
            "code": "2",
            "display": "In situ"
          },
          {
            "code": "3",
            "display": "Malignant, primary site"
          },
          {
            "code": "6",
            "display": "Malignant, metastatic site"
          },
          {
            "code": "9",
            "display": "Malignant, uncertain whether primary or metastatic site"
          }
        ]
      }
    ]
  }
}